In addition, PD-1/PD-L1 inhibitors are being investigated in clinical trials for many other cancers, such as prostate cancer, colorectal cancer, breast cancer, ovarian cancer, pancreatic cancer, gastric cancer, and glioblastoma. The gene discussed is PDCD1; the disease is cancer.